Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sheng, Jianhua
NCT03784222: Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients	Terminated	4	102	RoW	Blonanserin, MRI and serum BDNF	Sumitomo Pharma (Suzhou) Co., Ltd.	First Episode Schizophrenia, Social Function, Cognition Function, Blonanserin	11/22	11/22
NCT04859504: Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia	Completed	N/A	60	RoW	transcranial alternating current stimulation (NE Starstim)	Shanghai Mental Health Center	Schizophrenia, Transcranial Alternating Current Stimulations, Negative Symptoms	07/24	07/24
NCT03841019: Predict MDE Outcomes After MST	Completed	N/A	45	RoW	Magpro X100 + Option, ThymatronSystem Ⅳ Electroconvulsive System	Shanghai Mental Health Center	Major Depressive Episode	02/23	05/23
Tang, Yingying
NCT04859504: Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia	Completed	N/A	60	RoW	transcranial alternating current stimulation (NE Starstim)	Shanghai Mental Health Center	Schizophrenia, Transcranial Alternating Current Stimulations, Negative Symptoms	07/24	07/24